AVITA Medical, Inc. (RCEL) Non-Current Debt (2023 - 2025)

AVITA Medical (RCEL) has reported Non-Current Debt for 3 consecutive years, with $42.2 million the latest figure, recorded in Q2 2025.

• For the quarter ending Q2 2025, Non-Current Debt rose 2.99% year-over-year to $42.2 million; the trailing twelve-month figure through Jun 2025 stood at $42.2 million (up 2.99% YoY), and the FY2024 full-year result was $42.2 million, up 6.11% from the prior year.
• Non-Current Debt advanced to $42.2 million in Q2 2025 per RCEL's latest filing, from $41.5 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $42.5 million in Q3 2024 and bottomed at $39.8 million in Q4 2023.
• Historically, Non-Current Debt has averaged $41.5 million across 3 years, with a median of $41.5 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Non-Current Debt advanced 6.11% in 2024, then advanced 0.39% in 2025.
• Over 3 years, Non-Current Debt stood at $39.8 million in 2023, then grew by 6.11% to $42.2 million in 2024, then slipped by 0.07% to $42.2 million in 2025.
• According to Business Quant data, Non-Current Debt over the past three periods registered $42.2 million, $41.5 million, and $42.2 million for Q2 2025, Q1 2025, and Q4 2024 respectively.